• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How Can Allergen Immunotherapy Protect against COVID-19?

作者信息

Sokolowska Milena, Radzikowska Urszula

机构信息

Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland; and Christine Kühne - Center for Allergy Research and Education, Davos, Switzerland.

出版信息

Am J Respir Crit Care Med. 2023 May 15;207(10):1408-1410. doi: 10.1164/rccm.202302-0317LE.

DOI:10.1164/rccm.202302-0317LE
PMID:36989503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10595463/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5163/10595463/aeb950b5e79e/rccm.202302-0317LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5163/10595463/aeb950b5e79e/rccm.202302-0317LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5163/10595463/aeb950b5e79e/rccm.202302-0317LEf1.jpg

相似文献

1
How Can Allergen Immunotherapy Protect against COVID-19?变应原免疫疗法如何预防新冠病毒？
Am J Respir Crit Care Med. 2023 May 15;207(10):1408-1410. doi: 10.1164/rccm.202302-0317LE.
2
Influence of the COVID-19 pandemic on the prescription and adherence to allergen-specific immunotherapy.2019年冠状病毒病大流行对变应原特异性免疫疗法处方及依从性的影响。
Clin Exp Allergy. 2022 Jul;52(7):916-917. doi: 10.1111/cea.14115. Epub 2022 Apr 29.
3
A Comprehensive Overview of Allergen-specific Immunotherapy Types, Recombinant and Natural Extract Allergens in the Diagnosis and Treatment of Allergies.变应原特异性免疫治疗类型概述，重组和天然提取变应原在过敏诊断和治疗中的应用。
Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):494-511. doi: 10.18502/ijaai.v21i5.11038.
4
Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic: Management of venom allergen immunotherapy during the COVID-19 outbreak in Spain.评论：比洛·M·B、普拉韦托尼·V、毛罗·M、博纳多纳·P。新冠疫情期间治疗毒液过敏：西班牙新冠疫情爆发期间毒液变应原免疫疗法的管理
Allergy. 2021 Mar;76(3):951-952. doi: 10.1111/all.14567. Epub 2020 Oct 23.
5
Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial.变应原免疫疗法逆转过敏性鼻炎患者对SARS-CoV-2疫苗的免疫反应：一项前瞻性观察性试验。
Am J Respir Crit Care Med. 2022 Sep 15;206(6):780-783. doi: 10.1164/rccm.202203-0608LE.
6
[MECHANISMS OF ALLERGEN IMMUNOTHERAPY FOR INHALED ALLERGENS AND CLINICAL BIOMARKERS].[吸入性变应原的变应原免疫疗法机制及临床生物标志物]
Arerugi. 2018;67(8):987-994. doi: 10.15036/arerugi.67.987.
7
Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.重组变应原在变应原特异性免疫治疗中的应用：重组变应原免疫治疗 10 周年。
Allergy. 2011 Jun;66(6):775-83. doi: 10.1111/j.1398-9995.2011.02565.x. Epub 2011 Feb 26.
8
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.治疗用蜂毒变应原特异性免疫治疗提取液中主要过敏原含量的成分分析评估。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2482-2489. doi: 10.1080/21645515.2017.1323603. Epub 2017 May 11.
9
Allergen-specific immunotherapy and COVID-19: What happened?变应原特异性免疫治疗与 COVID-19：发生了什么？
Allergol Immunopathol (Madr). 2023 Mar 1;51(2):148-150. doi: 10.15586/aei.v51i2.796. eCollection 2023.
10
A brief history of allergen immunotherapy.变应原免疫治疗的简史。
Allergy Asthma Proc. 2022 Jul 1;43(4):248-253. doi: 10.2500/aap.2022.43.220023.

引用本文的文献

1
Type 2 immunity in allergic diseases.过敏性疾病中的2型免疫。
Cell Mol Immunol. 2025 Mar;22(3):211-242. doi: 10.1038/s41423-025-01261-2. Epub 2025 Feb 17.
2
Unveiling the interplay between influenza vaccination and SARS-CoV-2 immune responses.揭示流感疫苗接种与SARS-CoV-2免疫反应之间的相互作用。
Cent Eur J Immunol. 2024;49(1):1. doi: 10.5114/ceji.2024.139512. Epub 2024 May 9.
3
Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases.上皮屏障理论：暴露组、微生物组和屏障功能在过敏性疾病中的作用

本文引用的文献

1
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19.鼻病毒诱导的上皮细胞 RIG-I 炎性小体抑制抗病毒免疫并促进哮喘和 COVID-19 中的炎症。
Nat Commun. 2023 Apr 22;14(1):2329. doi: 10.1038/s41467-023-37470-4.
2
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial.变应原免疫治疗增强过敏性哮喘患者气道上皮的抗病毒免疫（VITAL 研究）：一项双盲随机对照试验。
Am J Respir Crit Care Med. 2023 May 1;207(9):1161-1170. doi: 10.1164/rccm.202209-1708OC.
3
Allergy Asthma Immunol Res. 2023 Nov;15(6):705-724. doi: 10.4168/aair.2023.15.6.705.
4
The relationship between sublingual immunotherapy for allergic rhinitis and the risk of symptoms in patients with COVID-19 infection.舌下免疫疗法治疗变应性鼻炎与 COVID-19 感染患者症状风险之间的关系。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2236538. doi: 10.1080/21645515.2023.2236538.
Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium.
人类气道上皮中 2 型炎症和病毒感染对血管紧张素转换酶 2 同工型的调节。
Mucosal Immunol. 2023 Feb;16(1):5-16. doi: 10.1016/j.mucimm.2022.12.001. Epub 2023 Jan 13.
4
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.哮喘表型与 COVID-19 风险：基于人群的观察性研究。
Am J Respir Crit Care Med. 2022 Jan 1;205(1):36-45. doi: 10.1164/rccm.202107-1704OC.
5
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy.变应原特异性免疫治疗期间固有淋巴细胞、单核细胞和树突状细胞中的训练免疫和免疫耐受。
J Allergy Clin Immunol. 2021 May;147(5):1865-1877. doi: 10.1016/j.jaci.2020.08.042. Epub 2020 Oct 9.
6
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.在健康人群以及哮喘、COPD、肥胖、高血压和 COVID-19 危险因素患者的组织和免疫细胞中，ACE2、CD147、CD26 和其他 SARS-CoV-2 相关分子的分布。
Allergy. 2020 Nov;75(11):2829-2845. doi: 10.1111/all.14429. Epub 2020 Aug 24.
7
House dust mite impairs antiviral response in asthma exacerbation models through its effects on TLR3.屋尘螨通过其对 TLR3 的影响，损害哮喘加重模型中的抗病毒反应。
Allergy. 2018 May;73(5):1053-1063. doi: 10.1111/all.13378. Epub 2018 Feb 5.
8
Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients.2 型细胞因子和组蛋白去乙酰化酶对哮喘患者气道上皮屏障完整性的调控。
J Allergy Clin Immunol. 2017 Jan;139(1):93-103. doi: 10.1016/j.jaci.2016.03.050. Epub 2016 May 11.
9
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.屋尘螨舌下变应原免疫治疗片剂治疗成人过敏性哮喘的疗效：一项随机临床试验。
JAMA. 2016 Apr 26;315(16):1715-25. doi: 10.1001/jama.2016.3964.